Wednesday, April 2, 2025

Healthcare

Mangoceuticals, Inc. (NASDAQ: MGRX) Secures Exclusive Rights to Diabetinol®, Entering $33.6 Billion Diabetes Market

Mangoceuticals, Inc. (NASDAQ: MGRX), operating as MangoRx, is a Dallas-based telemedicine company specializing in men's health and wellness. The company offers treatments for conditions...

MangoRx (NASDAQ: MGRX) Is Empowering Health and Wellness Through Innovation

MangoRx (NASDAQ: MGRX) is a health and wellness company dedicated to empowering individuals with effective solutions in key areas of personal well-being. The company...

NurExone Achieves 2025 TSX Venture 50™️ Milestone, Plans U.S. Growth and Beyond

(“NurExone” or the “Company”) (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) has been included in the 2025 TSX Venture 50™. For those living under a rock,...

NurExone: Pioneering Exosome Therapies for Vision and Spinal Cord Regeneration

NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a biopharmaceutical company developing exosome-based therapies for the multi-billion-dollar regenerative medicine market.  Among its...

NurExone Biologic Inc. and Its Competitors in Regenerative Medicine and Spinal Cord Injury Treatment

Regenerative medicine is revolutionizing the treatment of severe neurological injuries, particularly in cases of spinal cord damage. One company at the forefront of this...

Popular

Subscribe